Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestinal crypt stem cell | 4 studies | 20% ± 4% | |
paneth cell | 3 studies | 98% ± 3% |
Insufficient scRNA-seq data for expression of DEFA6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 57% | 11967.11 | 547 / 966 | 46% | 202.67 | 241 / 527 |
stomach | 23% | 3.76 | 81 / 359 | 36% | 102.16 | 104 / 286 |
spleen | 34% | 2.88 | 81 / 241 | 0% | 0 | 0 / 0 |
pancreas | 28% | 2.70 | 92 / 328 | 4% | 19.95 | 8 / 178 |
skin | 30% | 4.54 | 548 / 1809 | 0% | 0 | 0 / 472 |
bladder | 14% | 0.62 | 3 / 21 | 15% | 49.83 | 75 / 504 |
lung | 25% | 3.65 | 146 / 578 | 3% | 3.03 | 36 / 1155 |
thymus | 18% | 1.73 | 117 / 653 | 10% | 6.44 | 61 / 605 |
esophagus | 18% | 7.58 | 265 / 1445 | 8% | 17.98 | 14 / 183 |
liver | 25% | 3.00 | 56 / 226 | 1% | 0.18 | 4 / 406 |
adrenal gland | 23% | 2.53 | 60 / 258 | 0% | 0.03 | 1 / 230 |
prostate | 20% | 1.64 | 48 / 245 | 3% | 22.30 | 16 / 502 |
ovary | 22% | 2.11 | 40 / 180 | 0% | 0 | 0 / 430 |
uterus | 21% | 2.09 | 35 / 170 | 1% | 42.60 | 4 / 459 |
breast | 17% | 3.37 | 77 / 459 | 0% | 0.02 | 2 / 1118 |
adipose | 17% | 1.77 | 199 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 16% | 1.39 | 152 / 929 | 0% | 0 | 0 / 0 |
muscle | 16% | 1.20 | 129 / 803 | 0% | 0 | 0 / 0 |
heart | 13% | 1.29 | 116 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 13% | 1.89 | 177 / 1335 | 0% | 0 | 0 / 0 |
kidney | 12% | 0.94 | 11 / 89 | 0% | 0.01 | 1 / 901 |
brain | 11% | 0.89 | 296 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050829 | Biological process | defense response to Gram-negative bacterium |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0051673 | Biological process | disruption of plasma membrane integrity in another organism |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0031640 | Biological process | killing of cells of another organism |
GO_0002227 | Biological process | innate immune response in mucosa |
GO_0050832 | Biological process | defense response to fungus |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0019731 | Biological process | antibacterial humoral response |
GO_0005615 | Cellular component | extracellular space |
GO_0005796 | Cellular component | Golgi lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0030133 | Cellular component | transport vesicle |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DEFA6 |
Protein name | Defensin-6 (Defensin, alpha 6) |
Synonyms | DEF6 |
Description | FUNCTION: Host-defense peptide that contributes to intestinal innate immunity and mediates homeostasis at mucosal surfaces by forming higher-order oligomers that capture bacteria and prevent microbial invasion of the epithelium . After binding to bacterial surface proteins, undergoes ordered self-assembly to form fibril-like nanonets that surround and entangle bacteria and thereby prevent bacterial invasion across the epithelial barrier . Entangles and agglutinates Gram-negative bacteria, such as E.coli, S.typhimurium and Y.enterocolitica, and Gram-positive bacteria such as L.monocytogenes, thereby protecting the intestine against invasion by enteric bacterial pathogens . Blocks adhesion of C.albicans to intestinal epithelial cells and thereby suppresses fungal invasion of epithelial cells and biofilm formation . Under reducing conditions and in an acidic environment similar to the intestinal milieu, exhibits inhibitory activity against anaerobic bacteria such as B.adolescentis, L.acidophilus and B.breve, as well as B.longum and S.thermophilus, possibly by leading to alterations in bacterial cell envelope structures . The disulfide-linked oxidized form exhibits negligible antimicrobial activity against Gram-negative and Gram-positive bacteria, as compared to the enteric defensin DEFA5 . . |
Accessions | ENST00000646187.2 Q01524 ENST00000297436.3 |